A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

NCT03423628 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioblastoma Multiforme
Primary Glioblastoma Multiforme
Brain Neoplasms, Malignant
Leptomeningeal Disease (LMD)

Interventions

RADIATION: Radiation Therapy
DRUG: AZD1390
RADIATION: Radiation Therapy
RADIATION: Radiation Therapy
DRUG: AZD1390
DRUG: AZD1390

Sponsor

AstraZeneca